Patients
Reshaping the future of patient-centric drug development
Strategic partnerships, robust quality systems, and manufacturing know-how will support next-generation therapies with patient-centric designs.
R&D
Changing Faces: Pharma and biotech hires, June & July 2026
In June/July, companies continued to reshape their leadership teams in preparation for upcoming clinical, regulatory, and commercial milestones.
Sales & Marketing
Sponsored
Personalisation is the biggest lie brands keep telling
Pharma brands need to move beyond surface-level personalisation and focus on measurable impact.
Digital
Australia, AI, and Autolomous
pharmaphorum spoke with Alexander Seyf, CEO of Autolomous, about the future of AI in Australian biotech.
R&D
GLP-1 RAs in CKM management: A Q&A with CORXEL
GLP-1 RA medicine has transformed treatment of metabolic diseases such as obesity and diabetes. We spoke with China's CORXEL about theirs.
Sales & Marketing
Digital
Market Access
Editor's Picks
Editor's Picks
